Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Alkaloids Stories

Cocaine Addiction Never Goes Away
2013-09-23 13:00:17

Brett Smith for redOrbit.com - Your Universe Online The modern approach to handling an addiction is to recognize it as a disease that cannot be cured – only managed. A new study in the journal Biological Psychiatry reinforces this notion: that a recovering addict is constantly haunted by their days of substance abuse – even after a long period of abstinence. As researchers scramble to answer the 'chicken or the egg' questions surrounding addiction, they are becoming increasingly...

Additive Found In Dog Food May Prevent A Disabling Chemotherapy Side Effect
2013-09-20 08:47:59

April Flowers for redOrbit.com - Your Universe Online A chemical commonly used as a dog food preservative might prevent the kind of painful nerve damage found in the hands and feet of four out of five cancer patients taking the chemotherapy drug Taxol. A team of Johns Hopkins researchers have been working with cells in test tubes and mice to investigate the Food and Drug Administration (FDA)-approved dog food preservative. The preservative, an antioxidant called ethoxyquin, has been...

2013-09-17 11:09:09

Scientists at The Scripps Research Institute (TSRI) have found a way to make dramatic improvements to the cancer cell-killing power of vinblastine, one of the most successful chemotherapy drugs of the past few decades. The team’s modified versions of vinblastine showed 10 to 200 times greater potency than the clinical drug. Even more significantly, these new compounds overcome the drug resistance that emerges upon treatment relapse, which renders continued or subsequent vinblastine...

2013-09-16 08:30:18

Nearly Half of Current Non-Prescribers Anticipate Prescribing Xofigo in the Next Four to Six Months, According to a New Report from BioTrends Research Group EXTON, Pa., Sept. 16, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, at one month post-launch of Algeta/Bayer HealthCare's Xofigo in the United States, approximately one quarter of surveyed U.S. medical oncologists...

2013-09-16 08:28:33

SAN DIEGO, Sept. 16, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC QB: SRNE; Sorrento) announced today it will present the clinical data for Cynviloq(TM) (IG-001), which resulted in its approval as 1(st) line treatment of ovarian cancer by Korean FDA in March of 2013. Highlights of the findings include proof of non-inferiority of Cynviloq vs. Taxol in combination therapy with Carboplatin in patients with advanced epithelial ovarian cancer. These data will be presented at the...

2013-09-12 12:28:40

GLEN ALLEN, Va., Sept. 12, 2013 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) announced that the U.S. Patent and Trademark Office ("PTO") issued a Notice of Allowance on September 3, 2013 to Rock Creek Pharmaceuticals, Inc., its wholly owned subsidiary, in Application No. 13,477,295, covering anatabine citrate, the active component in the company's Anatabloc® products. A Notice of Allowance, issued by the PTO, is a notification that an applicant is entitled to a patent. The...

2013-09-10 08:30:25

SAN DIEGO, Sept. 10, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC QB: SRNE; Sorrento) announced today that it has secured an option to an exclusive license for the worldwide rights to Biomiga Diagnostics' (Biomiga) proprietary therapeutic drug monitoring (TDM) device for paclitaxel products. The license and option agreement allows Sorrento to utilize the TDM device for the clinical development of individualized dosing regimens of Sorrento's late-stage compound, Cynviloq(TM)...

2013-09-10 08:29:38

SAN DIEGO, Sept. 10, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC QB: SRNE; Sorrento) announced today that it has completed the merger with IgDraSol, Inc., a privately-held company focused on the development of cancer therapeutics. Upon the closing of the merger, IgDraSol shareholders will receive the equivalent of 3,047,968 million shares of Sorrento's common stock. Such issuance reflects Sorrento's recent reverse stock split, and based on the closing share price on...

Cocaine Rapidly Rewires Brain
2013-08-26 10:11:02

Michael Harper for redOrbit.com - Your Universe Online When mice are introduced to cocaine, the neurons in their brains become rapidly rewired to begin looking for the drug, even it if means not eating. Researchers from California now say this discovery could explain the first steps of addiction in humans. Armed with a microscope, some mice and a small amount of cocaine, the researchers introduced the animals to the drug and measured the growth of high-level brain circuits inside the...

2013-08-05 08:27:11

Official Minutes from End-of-Phase 2 FDA Meeting Provide Clarity on Next Steps SAN DIEGO and IRVINE, Calif., Aug. 5, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTCQB: SRNE; SRNED; Sorrento) and IGDRASOL announced today that IGDRASOL has received official meeting minutes from an End-of-Phase 2 meeting for Cynviloq(TM) (or IG-001) with the US Food and Drug Administration (FDA). Cynviloq(TM) (paclitaxel polymeric micelle) is initially under development for the treatment of...